Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

@article{Hill2001FrequencyOS,
  title={Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study},
  author={Catherine L. Hill and Yuqing Zhang and B{\'a}rdur Sigurgeirsson and Eero Pukkala and Lene Mellemkjaer and Antti Airio and Stephen R. Evans and David T. Felson},
  journal={The Lancet},
  year={2001},
  volume={357},
  pages={96-100}
}

Tables from this paper

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan

Patients with IIM are at increased risk for cancer and should receive age-appropriate and gender-appropriate malignancy evaluations, with additional assessment for nasopharyngeal, lung and hematologic malignancies following diagnosis, and with continued vigilance for development of cancers in follow-up.

Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort

The data indicate that the population prevalence of PM/DM in Caucasians is quite low, but underscores the complexity and severity of the disorders.

Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA

The incidence of cancer was increased in patients with DM compared to age- and sex-matched population controls, both over a 5-year interval surrounding the diagnosis of DM and over the lifetime interval following diagnosis.

Northern New England , USA Malignancy Is Associated with Dermatomyositis But Not Polymyositis in

The relationship between cancer and IIM was determined by conducting a retrospective review of 198 patients treated during the past 23 years at a single institution that functions both as a regional hospital and as a tertiary medical center.

articleCancer risks of dermatomyositis and polymyositis : a nationwide cohort study in Taiwan

Patients with IIM are at increased risk for cancer and should receive age-appropriate and genderappropriate malignancy evaluations, with additional assessment for nasopharyngeal, lung and hematologic malignancies following diagnosis, and with continued vigilance for development of cancers in follow-up.

Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.

In patients with tumor-associated myositis, it was more frequently necessary to administer other immunosuppressive drugs along with glucocorticoids, and the successful treatment of the underlying malignant disease improved the clinical course ofMyositis.

Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis

It is confirmed that CADM in addition to DM was associated with high rates of malignancy among the authors' patient cohort, and these features were independent predictive factors for developing malignancies in multiple logistic regression analysis.

Risk of Malignancy in Dermatomyositis and Polymyositis

Both DM and PM are associated with increased risk of malignancy, but the risk is higher in DM, while the overall relative risk was 4.66 for DM and 1.75 for PM.

Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases.

In this study, nasopharyngeal carcinoma represents the second cancer associated with DM, after breast neoplasm, demonstrating the frequency of these 2 cancers in this country.
...

References

SHOWING 1-10 OF 24 REFERENCES

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

The risk of cancer is increased in patients with polymyositis or dermatomyositis and there is also a higher rate of mortality from cancer.

Elevated cancer incidence in patients with dermatomyositis: a population based study.

DM is associated with cancer, but not PM, and the risk is high among patients with DM older than 49, and Cytotoxic drugs given to DM patients did not increase the risk of malignancies.

The overall and temporal association of cancer with polymyositis and dermatomyositis.

DM is associated with cancer, and the results suggest that DM is often paraneoplastic, but the high rate of malignancy only after PM diagnosis is consistent with cancer detection bias, but may suggest joint susceptibility of affected individuals to both cancer and myositis.

Gynecologic carcinoma associated with dermatomyositis-polymyositis.

In selected patients for whom more detailed follow-up information was available, the manifestations of dermatomyositis-polymyositis progressed and regressed in synchrony with tumor spread and effective treatment, respectively.

Gynecologic Carcinoma Associated With Dermatomyositis–Polymyositis

In selected patients for whom more detailed follow-up information was available, the manifestations of dermatomyositis-polymyositis progressed and regressed in synchrony with tumor spread and effective treatment, respectively.

Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases.

In Taiwan, dermatomyositis is associated with an increased incidence rate of nasopharyngeal carcinoma and should be performed in areas prevalent for nasoph throat carcinoma.

Dermatomyositis without Creatine Kinase Elevation

After reviewing the records of all adults with polymyositis/dermatomyositis seen at the University of Michigan since 1979, it became apparent that a normal creetine kinase level at the time of diagnosis was associated with a poor prognosis.

Polymyositis and dermatomyositis (first of two parts).

(First of Two Parts) POLYMYOSITIS is an inflammatory myopathy of unknown cause to which the term dermatomyositis is applied in the presence of the characteristic skin rash. These disorders share

Polymyositis, dermatomyositis and inclusion-body myositis.

  • M. Dalakas
  • Medicine
    The New England journal of medicine
  • 1991
The evolution over the past 10 years of rather well defined clinical, demographic, histologic, and immunopathological criteria and the identification of inclusion-body myositis as a distinct type of polymyositis now means the inflammatory myopathies now are considered to be pathogenetically similar.